BMY: Seagen Risk vs. Patent Cliff Discount; Fair Value $49.50
By stockpickr AI | March 1, 2026 | 10 min read
Investment Summary
BMY is trading at a discount relative to historical averages due to patent cliffs and integration risks from the Seagen acquisition, offering moderate upside potential following pipeline execution.
Investment Recommendation
Hold
Fair Value: $49.50
Current Price: $44.26
Upside/Downside: +11.84%
The DCF model suggests a fair value slightly above the current market price, indicating limited immediate upside given the near-term execution risks.
Key Metrics
- No metrics available